KLAT Chemie GmbH: Sale of Key Assets and Debt Restructuring
TRANSACTION ANNOUNCEMENT
GVG Corporate Finance Advisors Advises Klat Chemie GmbH on the Sale of Key Assets and Debt Restructuring
Wiesbaden, July 2013
GVG Corporate Finance Advisors has successfully advised Klat Chemie GmbH (KLAT) on the sale of key assets and debt restructuring.
Klat Chemie GmbH is a leading pharmaceutical company and dealer of veterinary medicines and high-quality nutritional supplements for livestock. The company focuses on the distribution of chemical-pharmaceutical products, which are predominantly manufactured by contract manufacturers in Germany. As a pharmaceutical company, KLAT holds pharmaceutical licenses for veterinary medicines and is actively involved in acquiring new approvals.
With these licenses, KLAT offers a comprehensive range of medicines for practicing veterinarians. In addition, the company exclusively distributes high-quality nutritional supplements through veterinarians.